Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
2020 · Science · 3,147 citations
https://doi.org/10.1126/science.abc6027
D
David Veyer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
120
Papers
11.2K
Citations
32
h-index
59
i10-index
David Veyer is an academic researcher from Délégation Paris 5. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Cervical Cancer and HPV Research. The author has an h-index of 32, co-authored 102 publications.
ORCID: 0000-0002-2911-0444Papers by this author
worksReduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
2021 · Nature · 2,151 citations
https://doi.org/10.1038/s41586-021-03777-9
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
2021 · Nature · 1,586 citations
https://doi.org/10.1038/s41586-021-04389-z
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
2024 · Nature Communications · 223 citations
https://doi.org/10.1038/s41467-024-46490-7
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
2023 · Nature Communications · 195 citations
https://doi.org/10.1038/s41467-023-36561-6
Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men
2018 · British Journal of Cancer · 51 citations
https://doi.org/10.1038/s41416-018-0176-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat